Palliative treatment of the advanced gastric cancer by means of surgery and HIPEC

被引:3
作者
Hoskovec, D. [1 ,2 ]
Varga, J. [2 ,3 ]
Antos, F. [2 ,3 ]
Kaspar, M. [2 ,4 ]
Vitek, P. [2 ,5 ]
Benkova, K. [6 ]
Dytrych, P. [1 ,2 ]
Konecna, E. [2 ,3 ]
机构
[1] Gen Univ Hosp, Dept Surg 1, CZ-12000 Prague 2, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[3] Univ Hosp Bulovka, Dept Surg, Prague, Czech Republic
[4] Univ Hosp Bulovka, Dept Radiodiagnost, Prague, Czech Republic
[5] Univ Hosp Bulovka, Inst Radiat Oncol, Prague, Czech Republic
[6] Univ Hosp Bulovka, Dept Pathol, Prague, Czech Republic
来源
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2013年 / 114卷 / 12期
关键词
gastric cancer; HIPEC; EPIC; radical surgery; peritoneal cytology; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; PERITONEAL CARCINOMATOSIS; CYTOREDUCTIVE SURGERY; METAANALYSIS;
D O I
10.4149/BLL_2013_154
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: We demonstrate a case report of the patient who suffered from advanced gastric cancer and was treated by means of surgery and HIPEC. Background: Gastric cancer is a therapeutic challenge in the European countries due to late diagnosis, advanced stages of the disease in time of diagnosis and early recurrence in cases where a radical surgery is possible. Method: The patient with an advanced gastric cancer (pT3N2M1 - peritoneal and ovarian metastases) was treated by means of radical surgery in combination with hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) and early postoperative intraperitoneal chemotherapy (EPIC). Surgical treatment was followed by a standard chemotherapy. Due to recurrence, there was the second look surgery one year later again with HIPEC procedure. Results: Patient survived 32 months after diagnosis and despite intraperitoneal recurrence she never developed clinically significant ascites and she never suffered from intestinal obstruction. Conclusion: This case demonstrate a potential benefit of new oncosurgical approach -radical surgery + HIPEC + EPIC in the treatment of gastric cancers (Tab. 2, Fig. 6, Graph 4, Ref. 18). Text in PDF www.elis.sk.
引用
收藏
页码:735 / 739
页数:5
相关论文
共 16 条
[1]  
Becker HD, 2005, CHIRURG ONKOLOGIE
[2]  
Deraco M., 2007, EUR ONCOL DIS
[3]  
EUNE for Gastric Cancer Steering Group, 2008, BRIT J SURG, V95, P406
[4]   Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy [J].
Glehen, Olivier ;
Gilly, Francois Noel ;
Arvieux, Catherine ;
Cotte, Eddy ;
Boutitie, Florent ;
Mansvelt, Baudouin ;
Bereder, Jean Marc ;
Lorimier, Gerard ;
Quenet, Francois ;
Elias, Dominique .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (09) :2370-2377
[5]   Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [J].
Glockzin, Gabriel ;
Schlitt, Hans J. ;
Piso, Pompiliu .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2009, 7
[6]   Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer [J].
Hall, JY ;
Loggie, BW ;
Shen, P ;
Beamer, S ;
Case, LD ;
McQuellon, R ;
Geisinger, KR ;
Levine, EA .
JOURNAL OF GASTROINTESTINAL SURGERY, 2004, 8 (04) :454-463
[7]  
JCGA, INTR JGCA GASTR CANC
[8]   Curative treatment of gastric cancer: towards a multidisciplinary approach? [J].
Roth, AD .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003, 46 (01) :59-100
[9]   Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: A single western center experience [J].
Scaringi, S. ;
Kianmanesh, R. ;
Sabate, J. M. ;
Facchiano, E. ;
Jouet, P. ;
Coffin, B. ;
Parmentier, G. ;
Hay, J. M. ;
Flamant, Y. ;
Msika, S. .
EJSO, 2008, 34 (11) :1246-1252
[10]  
Sugerbaker PH, 1998, MANAGEMENT PERITONEA